|
<section><section powered-by="gulangu"><section><section><section data-role="paragraph" data-color="rgb(182, 228, 253)" data-custom="rgb(182, 228, 253)"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section><p><p><img src="image/20201014/86b79d371e9862b01189f0252a03b2cd_1.png" /></p></p></section><section><section><span><strong></strong></span></section><p><span>医疗器械媒体报道先锋</span></p><p><span>分享专业医疗器械知识</span></p></section><section><section><section>关注</section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><p><strong><span>来源:</span></strong></p><p><strong><span><br /></span></strong></p><p>脂肪和肌肉的不平衡与许多慢性疾病有关。虽然这些年医学取得了很大的进步,但身体成分评估仍然是不精确和非个人的。在现代医疗保健和精准医学的时代,医生和患者都期待并更多高质量的信息。医生需要一个新的标准,一种精确,经济有效的方式来了解个人的身体。</p><p><br /></p><p>身体成分概况(BCP)是AMRA开创性的代谢评估方法,这是一种多维可视化,可以同时评估脂肪和肌肉分布,脂肪堆积模式以及脂肪库之间的平衡。</p></section></section></section><section powered-by="gulangu"><section><section><p><br /></p></section></section></section><section powered-by="gulangu"><section><section><p><img src="image/20201014/7555d6bf38fc250aa776458ddcb0f771_2.jpg" /></p></section></section></section><section powered-by="gulangu"><section><section><p><br /></p></section></section></section><section powered-by="gulangu"><section><section><p>AMRA Profiler是第一款能够将MRI图像转换为高质量3D脂肪和肌肉图谱并提供患者身体代谢状态的产品。具体而言,该技术提供了关于内脏脂肪组织体积,皮下脂肪组织体积,肝脏脂肪分数和大腿肌肉体积的视觉和基于值的信息。<span>总部位于瑞典林雪平的AMRA Medical日前宣布其AMRA Profiler技术已获FDA认证。</span></p><p><br /></p></section></section></section><section powered-by="gulangu"><section><section><p><img src="image/20201014/7ae3f2137f4cff5f8344102c090604bc_3.jpg" /></p></section></section></section><section powered-by="gulangu"><section><section><p><br /></p></section></section></section><section powered-by="gulangu"><section><section><p>AMRA主要在1.5和3T MR扫描仪上进行了标准化,具有精确的测量结果,可以识别身体成分变化和治疗影响的早期迹象。</p><p><br /></p><p><p><img src="image/20201014/b9f639ab6939785ff2f9bf7222113fbb_4.png" /></p></p><p><br /></p></section></section></section><section powered-by="gulangu"><section><section><p><br /></p><p>单次6分钟MRI扫描,多次测量的自动分析,与其他成像协议和技术很好地集成。 AMRA Profiler确实需要兼容的MRI扫描仪,并且该公司与供应商合作以确保安装产品,以便接收每个获得适当扫描的患者的身体成分分析报告所需的交互非常少。</p><p><br /></p><p>“我们很高兴FDA的决定。世界各地的医疗保健系统所面临的挑战都有充分的记录。成本限制以及肥胖和人口老龄化等社会问题正在使医院和私人诊所面临越来越大的压力,”AMRA医疗公司首席执行官Eric Converse表示。“AMRA?Profiler通过为医生提供最详细的身体成分评估和成像,经济高效且对患者的侵入最小化,帮助解决这些挑战。最终,这使临床医生能够对整个身体做出更明智的治疗决策。”</p><p><br /></p></section></section></section></section><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#374aae"><p><strong><span>本文由翻译/整理自外网,转载请注明出处。</span></strong></p></section></section><section data-role="outer" label="Powered by gulangu"><p> </p><section data-id="1658"><section><section><section data-id="1658"><section><section><section data-id="1658"><section><section><section data-id="1658"><section><section><p><span><strong>相关阅读</strong></span></p></section><p><p><img src="image/20201014/ec237188ae1e9c03eb4d9814f31b18ab_5.gif" /></p></p><p><br /></p><p><span>如何优雅地通过外形区分CT和MRI?</span><br /></p><p><br /></p><p><span>全世界都说血管支架术后能做磁共振 你为什么不让做</span><br /></p><p><br /></p><p><span>科普动画|如何向别人解释MRI是怎么成像的?</span><br /></p><p><br /></p><p><span>重磅!世界首台高场强MRI放疗系统获FDA认证!</span><br /></p></section></section></section></section></section></section></section></section></section></section></section><p><br /></p><p><span><strong><span><p><img src="image/20201014/225eae26a91575de7508aebe3e999278_6.jpg" /></p></span></strong></span></p></section><p><br /></p>
|
|